Skip to main content
Chabiotech Co.,Ltd. logo

Chabiotech Co.,Ltd. — Investor Relations & Filings

Ticker · 085660 ISIN · KR7085660009 KO Professional, scientific and technical activities
Open in API
Filings indexed 460 across all filing types
Latest filing 2024-06-03 Report Publication Anno…
Country KR South Korea
Listing KO 085660

About Chabiotech Co.,Ltd.

http://en.chabio.com/

Chabiotech Co., Ltd. is a biotechnology company specializing in the research and development of cell and gene therapies for rare cancers and incurable diseases. The company's core activities include advancing its therapeutic pipelines and providing global Contract Development and Manufacturing Organization (CDMO) services for advanced biopharmaceuticals, including full-scale GMP production and testing. Chabiotech also operates bio-banking services, such as cord blood and immune/stem cell storage, utilizing advanced cryopreservation technology. Its diversified business segments extend to genomics for precision medicine, healthcare IT solutions that integrate AI and Big Data, comprehensive wellness programs, and specialized healthcare consulting.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and details of an Investor Relations (IR) event ('기업설명회(IR) 개최') at the 2024 BIO USA convention. It provides the date, location, purpose, and contact information for the event. Since it is an announcement of an upcoming presentation rather than the presentation slides themselves, and it does not fit into specific categories like earnings releases or financial reports, it is classified as a Regulatory Filing (RNS) which serves as the standard category for such corporate event notifications in this taxonomy.
2024-06-03 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's representative director (CEO). It details the transition from joint representative directors to a sole representative director, provides the reason for the change (resignation), and lists the new representative's details and career history. This falls directly under the category of board/management changes.
2024-05-31 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document details the shareholding status of a major shareholder (Cha Kwang-yul) and their special related parties in the company 'Cha Biotech'. It includes specific sections on shareholding ratios, changes in holdings, and details of collateral contracts. This falls under the 'Major Shareholding Notification' category.
2024-05-27 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a private placement of convertible bonds) by Cha Biotech. It details the issuance amount, payment date, and the nature of the securities. This falls under the category of capital and financing updates, specifically related to the issuance of debt/equity instruments.
2024-05-16 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from Cha Biotech regarding the results of a securities issuance (specifically a private placement of bonds with warrants). It details the issuance amount, payment date, and type of security. This falls under the category of capital and financing updates as it reports on the completion of a financing activity.
2024-05-16 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically, third-party allocated paid-in capital increase via redeemable convertible preferred shares). It details the number of shares issued, the total amount, and the payment date. This falls under the category of share issuance and capital changes.
2024-05-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.